Backbone dynamics of the human CC chemokine eotaxin: Fast motions, slow motions, and implications for receptor binding

Protein Science

Volumn 8, Issue 10, 1999, Pages 2041-2054

  Crump, Matthew P ^a   Spyracopoulos, Leo ^a   Lavigne, Pierre ^a   Kim, Key Sun ^b   Clark Lewis, Ian ^c   Sykes, Brian D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Korea Institute of Science and Technology   (South Korea)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Backbone 15N dynamics; CC chemokine; Conformational exchange; Eotaxin; Monomer dimer equilibrium

Indexed keywords

AMINO ACID; BETA CHEMOKINE; CHEMOKINE RECEPTOR; EOTAXIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISULFIDE BOND; HUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STRUCTURE; RECEPTOR BINDING;

EID: 0032880414     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.8.10.2041     Document Type: Article

References (51)

1. Ahragam A. 1961. Principles of nuclear magnetism. Oxford, UK: Clarendon Press.
2. Baggiolini M, Dewald B, Moser B. 1997. Human chemokines: An update. Annu Rev Immunol 15:675-705.
3. nd ed. New York: McGraw-Hill.
4. Clark-Lewis I, Dewald B, Loetscher M, Moser B, Baggiolini M. 1994. Structural requirements for interleukin-8 function identified by design of analogs and CXC chemokine hybrids. J Biol Chem 269:16075-16081.
5. Clark-Lewis I, Kim KS, Rajarathnam K, Gong J-H, Dewald B, Moser B, Baggiolini M, Sykes BD. 1995. Structure-activity relationships of chemokines. J Leukocyte Biol 57:703-711.
6. 1H NMR spectroscopy. Biochemistry 29:7387-7401.
7. Clore GM, Szabo A, Bax A, Kay LE, Driscoll PC, Gronenborn AM. 1990b. Deviations from the simple two-parameter model-free approach to the interpretation of nitrogen-15 nuclear magnetic relaxation of proteins. J Am Chem Soc 112:4989-4991.
8. Corrigan CJ, Kay AB. 1992. T-cells and eosinophils in the pathogenesis of asthma. Immunol Today 13:501-507.
9. Crump MP, Gong J-H, Loetscher P, Rajarathnam K, Amara A, Arezana-Seisedos F, Virelizier J-L, Baggiolini M, Sykes BD, Clark-Lewis I. 1997. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J 16:6996-7007.
10. Crump MP, Rajarathnam K, Kim K-S, Clark-Lewis I, Sykes BD. 1998. Solution structure of eotaxin, a chemokine that selectively recruits eosinophils in allergic inflammation. J Biol Chem 273:22411-22479.
11. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A. 1995. NMRpipe: A multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6:277-293.
12. Fairbrother WJ, Skelton NJ. 1996. Three dimensional structures of the chemokine family. In Horuk R, ed. Chemoattractant ligands and their receptors. London, UK: CRC Press. pp 55-86.
13. 15N-relaxation. Biochemistry 33:5984-6003.
14. Farrow NA, Zhang O, Forman-Kay JD, Kay LE. 1995. Comparison of the backbone dynamics of a folded and an unfolded SH3 domain existing in equilibrium in aqueous buffer. Biochemistry 34:868-878.
15. Gagné SM, Tsuda S, Spyracopoulos L, Kay LE, Sykes BD. 1998. Backbone and methyl dynamics of the regulatory domain of troponin C: Anisotropic rotational diffusion and contribution of conformational entropy to calcium affinity. J Mol Biol 278:667-686.
16. Garrett DS, Powers R, Gronenborn AM, Clore GM. 1991. A common sense approach to peak picking in two-, three, and four-dimensional spectra using automatic computer analysis of contour diagrams. J Magn Reson 95:214-220.
17. Goldman M. 1984. Interference effects in the relaxation of a pair of unlike spin one-half nuclei. J Magn Reson 60:437-452.
18. Gong J-H, Uguccioni M, Dewald B, Baggiolini M, Clark-Lewis I. 1996. RANTES and MCP-3 antagonists bind multiple chemokine receptors. J Biol Chem 271:10521-10527.
19. 15N relaxation measurements. J Mol Biol 230:364-372.
20. Griffiths-Johnson DA, Collins PD, Rossi AG, Jose PJ, Williams TJ. 1993. The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation in the lung in vivo. Biochem Biophys Res Commun 197:1167-1172.
21. Hyberts SG, Goldberg MS, Havel TF, Wagner G. 1992. The solution structure of eglin c based on measurements of many NOEs and coupling constants and its comparison to the X-ray structure. Protein Sci 1:736-751.
22. Jeener J, Meier BH, Bachmann P, Ernst RR. 1979. Investigation of exchange processes by two-dimensional NMR spectroscopy. J Chem Phys 71:4546-4553.
23. Jose PJ, Griffiths-Johnson DA, Collins PD, Walsh DT, Moqbel R, Totty NF, Truong O, Hsuan JJ. 1994. Eotaxin: A potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 179:881-887.
24. Katoh E, Yamazaki T, Kiso Y, Wingfield PT, Stahl SJ, Kaufman JD, Torchia DA. 1999. Determination of the rate of monomer interchange in a ligand bound homodimeric protein from NOESY crosspeaks: Application to HIV protease/KNI-529 complex. J Am Chem Soc 121:2607-2608.
25. 2 values in proteins. J Magn Reson 97:359-375.
26. 15N inverse detected heteronuclear NMR spectroscopy: Application to staphylococcal nuclease. Biochemistry 28:8972-8979.
27. Kim K-S, Rajarathnam K, Clark-Lewis I, Sykes BD. 1996. Structural characterization of a monomeric chemokine: Monocyte chemoattractant protein-3. FEBS Lett 395:277-282.
28. Kitaura M, Nakajima T, Imai T, Harada S, Combadiere C, Lee Tiffany H, Murphy PM, Yoshie O. 1996. Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J Biol Chem 271:7725-7730.
29. 15N NMR spectroscopy. Biochemistry 13:4856-4866.
30. Laurence JS, LiWang AC, LiWang PJ. 1998. Effect of N-terminal truncation and solution conditions on chemokine dimer stability: Nuclear resonance structural analysis of macrophage inflammatory protein-1β mutants. Biochemistry 37:9346-9354.
31. Lipari G, Szubo A. 1982a. A model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules I. Theory and range of validity. J Am Chem Soc 104:4545-4549.
32. Lipari G, Szabo A. 1982b. A model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules II. Theory and range of validity. J Am Chem Soc 104:4549-4570.
33. LiWang AC, Cao JJ, Zheng H, Lu Z, Peiper SC, LiWang PJ. 1999. Dynamics study on the anti-human immunodeficiency virus chemokine viral macrophage-inflammatory Protein-II (vMIP-II ) reveals a fully monomeric protein. Biochemistry 38:442-453.
34. Lowman HB, Slagle PH, DeForge LE, Wirth CM, Gillece-Castro BL, Bourell JH, Fairbrother WJ. 1996. Exchanging interleukin-8 and melanoma growth-stimulating activity receptor binding specificities. J Biol Chem 271: 14344-14352.
35. Lubkowski J, Bujacz G, Boqué L, Domaille PJ, Handel TM, Wlodawer A. 1997. The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary structures. Nat Struct Biol 4:64-69.
36. McConnell HM. 1958. Reaction rates by nuclear magnetic resonance. J Chem Phys 28:430-431.
37. 3CR1. Biochemistry 38: 1402-1414.
38. Pakianathan DR, Kuta EG, Artis DR, Skelton NJ, Hébert CA. 1997. Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3, and CCR5. Biochemistry 36:9642-9648.
39. Palmer AG. 1993. Dynamic properties of proteins using NMR spectroscopy. Curr Opin Biotechnal 4:385-391.
40. Ponath PD, Qin S, Ringler DJ, Clark-Lewis I, Wang J, Kassam N, Smith H, Shi X, Gonzalo J-A, Newman W, et al. 1996. Cloning of the human eosinophil chemoattractant, eotaxin. J Clin Invest 97:604-612.
41. Rajarathnam K, Sykes BD, Dewald B, Baggiolini M, Clark-Lewis I. 1999. Disulfide bridges in interleukin-8 probed using non-natural disulfide analogues: Dissociation of roles in structure from function. Biochemistry 38:7653-7658.
42. Rajarathnam K, Sykes BD, Kay CM, Geiser T, Dewald B, Baggiolini M, Clark-Lewis I. 1994. Neutrophil activation by monomeric interleukin-8. Science 264:90-92.
43. Sallusto F, Mackay CR, Lanzavecchia A. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277:2005-2007.
44. Schraufstätter IU, Ma M, Oades ZG, Barritt DS, Cochrane CG. 1995. The role of Tyr13 and Lys15 of interleukin-8 in the high affinity interaction with the interleukin-8 receptor type A. J Biol Chem 270:10428-10431.
45. Skelton NJ, Quan C, Reilly D, Lowman H. 1999. Structure of a complex between interleukin-8 and a CXCR-1 receptor based peptide. Structure 7:157-168.
46. Smallcombe SH. 1993. Solvent suppression with symmetrically shifted pulses. J Am Chem Soc 115:4776-4785.
47. Szyperski T, Luginbühl P, Otting G, Wüthrich K. 1993. Protein dynamics studied by rotating frame 15N spin relaxation times. J Biomol NMR 3:151-164.
48. 15N NMR relaxation. J Am Chem Soc 117:12562-12566.
49. 15N NMR relaxation measurements at two magnetic fields. J Biomol NMR 8:273-284.
50. Wagner G. 1993. NMR relaxation and protein mobility. Curr Opin Struct Biol 3:748-753.
51. Yang D, Kay LE. 1996. Contributions to conformational entropy arising from bond vector fluctuations measured from NMR-derived order parameters: Application to protein folding. J Mol Biol 263:369-382.